

Retatrutide 32 mg + MOTS-C 32 mg
Pens bought separately IDR 6,900,000
Original documents
Open the original PDF published with this product. Check the report’s batch reference against the pack you are ordering.
Need a report for a particular batch? Ask our team on WhatsApp.
About the compound
Retatrutide is a peptide studied for its activity at GLP-1, GIP and glucagon receptors. These signaling pathways connect appetite, nutrient handling and energy metabolism. This is why it is described as a triple receptor agonist.
The phase 2 study linked below examined body-weight changes in adults with obesity over 48 weeks. The study used a specified clinical formulation and monitored participants; it did not test this finished 32 mg Body Pharm pen.
These sources describe the compounds and study settings, rather than clinical testing of this finished Body Pharm pen.
For research and educational use only. Not for human or veterinary consumption. These products are research compounds and are not approved as medicines.